Industry Background:
Ibuprofen is a non steroidal anti-inflammatory drug (NSAIDs) used as a painkiller as well as for treating fever and inflammation. This medication can be available to take without doctor's prescriptions. It also pain and inflammation caused by conditions that effect joints, bones, and muscles. In addition to this, Ibuprofen also reduces migraine, toothache and others. It was initially developed in 1960 while researching for a safer alternative for aspirin.
This growth is primarily driven by Increasing Adoption of Painkillers in Acute Pain Conditions, Improving interdependence on Analgesic Medication in case of IV Ibuprofen and Huge demand in the market with Minimum Competition.
Globally, a noticeable market trend is evident Adoption of Ibuprofens with minimized cardiovascular side effects
. The Chemicals sector in the United States region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Vendors, such as Xinhua Pharmaceutical (China), IOLCP (India), Granules Biocause (China), Strides Pharma Science Limited. (India), BASF (Germany), SI Group, Inc. (United States), Xinhua-Perrigo Pharmaceutical (China), Hisoar (China), Unipex (France) and Rochem (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
On 9th August, 2018, SI Group Inc. has announced that it will be increasing its capacity for ibuprofen manufacture by 25%, to be completed by 2020.
Regulatory Insights:
"The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has said that patients taking ibuprofen at doses of 2,400 mg or more per day are at a higher risk of heart attack or stroke than those taking lower doses." and "Practs Committee has stated that the level of risk will not increase when taking up to 1,200 mg of ibuprofen, which is typically the highest recommended dose for OTC versions."
Market Drivers
- Increasing Adoption of Painkillers in Acute Pain Conditions
- Improving interdependence on Analgesic Medication in case of IV Ibuprofen
- Huge demand in the market with Minimum Competition
Market Trend
- Adoption of Ibuprofens with minimized cardiovascular side effects
- Introduction to Ibuprofen Gel
Restraints
- Posses Number of Side Effects including Nausea, Upsets Stomach, Vomiting, Headache, Diarrhea
- This medication can increase the patient's blood pressure
- Pose some serious threats to Kidney
Opportunities
Demand for Ibuprofen is the most as compared to its productivity and Opportunities in untapped markets where the government subsidies can assist in upsurging demand
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Vendors landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Ibuprofen Sales Study Sheds Light on
The Ibuprofen Sales Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Ibuprofen Sales industry Vendors. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Ibuprofen Sales industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
How every company in this diverse set of Vendors can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.